ArticleJournal of translational medicine2020

Poor clinical outcome in metastatic melanoma is associated with a microRNA-modulated immunosuppressive tumor microenvironment.

Natasha A N Jorge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.